Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,070.62
+1.160.06%
Number of Gainers:307
Number of Losers:692
Number of Flat:25
PE:- -
High:2,074.58
Open:2,069.14
Low:2,058.61
Close:2,069.46
Volume:5.73B
Turnover:691.07B
Market Cap:96.45T
Float Cap:90.18T

Loading ...

Technology Select Sector SPDR: Pivot points

TIPRANKS
·
Sep 09

Five new option listings on September 9th

TIPRANKS
·
Sep 09

Evercore ISI Initiates Coverage on Cigna Group With In Line Rating, $290 Price Target

MT Newswires Live
·
Sep 09

Academy Sports and Outdoors Jumps After Raising Annual Profit Forecast

Reuters
·
Sep 09

Xeris Biopharma hosts webinar on XP-8121 development program

TIPRANKS
·
Sep 09

Scotiabank Adjusts Price Target on Oracle to $215 From $241, Keeps Sector Outperform Rating

MT Newswires Live
·
Sep 09

Beijing Launches Joint Insurance Body for Biopharma Sector to Strengthen Safeguards for Innovative Medicine Industry

Deep News
·
Sep 09

油市飙升与回购悬念令美债承压 投资者入场心态趋谨慎

Deep News
·
Sep 09

MBody AI Advances AI Robotics Rollout at Mohegan Sun

GlobeNewswire
·
Sep 09

Mint Incorporation Limited Strikes MENA Education Robotics Distribution Deal via Rice Robotics AGI

TIPRANKS
·
Sep 09

Schouw & Co. to Host Capital Markets Day for Investors and Analysts

Reuters
·
Sep 09

Galmed Rebrands as EoCene, Secures Nasdaq Compliance and Ends Yorkville Equity Line

TIPRANKS
·
Sep 09

Simon Property Group: Offering Unsecured Notes Due 2032 and 2036; Size not Disclosed - SEC Filing

THOMSON REUTERS
·
Sep 09

Genuine Parts Names Court Carruthers CEO-Elect Ahead of Planned Split-Off Motion Unit

Reuters
·
Sep 09

BTCS CEO Charles Allen to Speak at H.C. Wainwright Annual Global Investment Conference Panel

Reuters
·
Sep 09

IDT NRSInsights: August Same-Store Sales Fall 1.1% Y/y

Reuters
·
Sep 09

Birchtech to Start USD 5 Million Share Buyback Sept. 14

Reuters
·
Sep 09

SalesCloser to Host Investor Webinar, CEO and CFO to Present Platform Demo

Reuters
·
Sep 09

Draganfly Names Retired Colonel Kevin Leblond VP, Canadian Defence and Security

Reuters
·
Sep 09

Propanc Biopharma Plans First-in-Human Phase 1b PRP Trial Start in February 2027

Reuters
·
Sep 09